Compare · BLCO vs LUCY
BLCO vs LUCY
Side-by-side comparison of Bausch + Lomb Corporation (BLCO) and Innovative Eyewear Inc. (LUCY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLCO and LUCY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- BLCO is the larger of the two at $6.16B, about 668.8x LUCY ($9.2M).
- BLCO has been more active in the news (23 items in the past 4 weeks vs 12 for LUCY).
- BLCO has more recent analyst coverage (19 ratings vs 0 for LUCY).
- Company
- Bausch + Lomb Corporation
- Innovative Eyewear Inc.
- Price
- -
- -
- Market cap
- $6.16B
- $9.2M
- 1M return
- -
- +35.96%
- 1Y return
- -
- -45.96%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- 2022
- News (4w)
- 23
- 12
- Recent ratings
- 19
- 0
Bausch + Lomb Corporation
Bausch + Lomb Corporation operates as an eye health company in Canada and internationally. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that cover the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions. It offers intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Latest BLCO
- Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
- Director Trebbi Barbara was granted 11,776 shares (SEC Form 4)
- SEC Form 3 filed by new insider Trebbi Barbara
- Director Paul Laurence E was granted 11,776 shares (SEC Form 4)
- SEC Form 3 filed by new insider Paul Laurence E
- Director Chersi Robert J was granted 11,776 shares (SEC Form 4)
- SEC Form 3 filed by new insider Chersi Robert J
- New insider Appio Thomas claimed ownership of 27,583 shares (SEC Form 3)
- SVP, Controller and CAO Munsch Frederick sold $887,662 worth of shares (52,900 units at $16.78), decreasing direct ownership by 54% to 45,831 units (SEC Form 4)
- Amendment: SEC Form 8-K/A filed by Bausch + Lomb Corporation
Latest LUCY
- Chief Financial Officer Gayle Oswald was granted 32,466 shares and sold $13,491 worth of shares (15,533 units at $0.87), increasing direct ownership by 591% to 19,798 units (SEC Form 4)
- Chief AI & Growth Officer Dabrowski Konrad sold $11,874 worth of shares (13,627 units at $0.87) and was granted 41,800 shares, increasing direct ownership by 220% to 40,977 units (SEC Form 4)
- Chief Operating Officer Abondano Joaquin was granted 29,600 shares and sold $8,414 worth of shares (9,799 units at $0.86), increasing direct ownership by 380% to 25,012 units (SEC Form 4)
- Chief Executive Officer Gross Harrison R. was granted 49,200 shares and sold $24,411 worth of shares (27,738 units at $0.88), increasing direct ownership by 156% to 35,195 units (SEC Form 4)
- Chief Technology Officer Cohen David Eric was granted 36,400 shares and sold $14,587 worth of shares (15,769 units at $0.93), increasing direct ownership by 307% to 27,342 units (SEC Form 4)
- Innovative Eyewear, Inc. Announces Strategic Alliance with HTC Corporation
- Innovative Eyewear Announces Expansion Into More than 150 Stores of One of the Largest Big Box Retailers in the United States
- Innovative Eyewear, Inc. Announces Major New AI and News Features for Lucyd App
- SEC Form 10-Q filed by Innovative Eyewear Inc.
- Innovative Eyewear Inc. Reports Record Second Quarter 2026 Results